Compoundeer Logo
COMPOUNDEER
Uncovering Potential
RankingCompaniesDCF
MD Logo

Pediatrix Medical Group, Inc.

MD

Services-Hospitals

Mkt Cap

$605.7M

PE

-8.58

Debt

$16.41M

Cash

$7.998M

EV

$614.1M

FCF

$92.44M

Market Cap

$605.7M

P/E Ratio

-8.58

Debt

$16.41M

Cash

$7.998M

EV

$614.1M

FCF

$92.44M
Charts data: {"Earnings":[{"time":"2014-12-30","value":317203000},{"time":"2015-12-30","value":335691000},{"time":"2016-12-30","value":324596000},{"time":"2017-12-30","value":320372000},{"time":"2018-12-30","value":268629000},{"time":"2019-12-30","value":-1497702000},{"time":"2020-12-30","value":-796488000},{"time":"2021-12-30","value":130937000},{"time":"2022-12-30","value":66331000},{"time":"2023-12-30","value":-60408000}],"Sales":[{"time":"2014-12-30","value":2438913000},{"time":"2015-12-30","value":2779996000},{"time":"2016-12-30","value":3183159000},{"time":"2017-12-30","value":3458312000},{"time":"2018-12-30","value":3647123000},{"time":"2019-12-30","value":3513542000},{"time":"2020-12-30","value":1733951000},{"time":"2021-12-30","value":1911191000},{"time":"2022-12-30","value":1972021000},{"time":"2023-12-30","value":1994640000}],"Net Margins":[{"time":"2014-12-30","value":0.13005916980228488},{"time":"2015-12-30","value":0.12075233201774391},{"time":"2016-12-30","value":0.10197291432818782},{"time":"2017-12-30","value":0.09263825820226747},{"time":"2018-12-30","value":0.07365504261852425},{"time":"2019-12-30","value":-0.4262655747391094},{"time":"2020-12-30","value":-0.45934862057809017},{"time":"2021-12-30","value":0.06851068260576781},{"time":"2022-12-30","value":0.03363605154306166},{"time":"2023-12-30","value":-0.03028516424016364}],"Assets":[{"time":"2014-12-30","value":3608795000},{"time":"2015-12-30","value":4547214000},{"time":"2016-12-30","value":5339400000},{"time":"2017-12-30","value":5867278000},{"time":"2018-12-30","value":5934911000},{"time":"2019-12-30","value":4145901000},{"time":"2020-12-30","value":3347948000},{"time":"2021-12-30","value":2722546000},{"time":"2022-12-30","value":2347887000},{"time":"2023-12-30","value":2219810000}],"Stockholders Equity":[{"time":"2014-12-30","value":2265566000},{"time":"2015-12-30","value":2437846000},{"time":"2016-12-30","value":2760767000},{"time":"2017-12-30","value":3066454000},{"time":"2018-12-30","value":3087884000},{"time":"2019-12-30","value":1498996000},{"time":"2020-12-30","value":747717000},{"time":"2021-12-30","value":896692000},{"time":"2022-12-30","value":891632000},{"time":"2023-12-30","value":849061000}],"ROE":[{"time":"2014-12-30","value":0.14001048744552133},{"time":"2015-12-30","value":0.1376998382998762},{"time":"2016-12-30","value":0.11757457257349135},{"time":"2017-12-30","value":0.10447637564431099},{"time":"2018-12-30","value":0.08699452440570954},{"time":"2019-12-30","value":-0.9991367555350381},{"time":"2020-12-30","value":-1.0652265496170343},{"time":"2021-12-30","value":0.14602226851583375},{"time":"2022-12-30","value":0.07439279882283274},{"time":"2023-12-30","value":-0.0711468316175163}],"ROA":[{"time":"2014-12-30","value":0.1421524359239026},{"time":"2015-12-30","value":0.12268347168178141},{"time":"2016-12-30","value":0.10706952091995356},{"time":"2017-12-30","value":0.08182261007574551},{"time":"2018-12-30","value":0.07512294624131685},{"time":"2019-12-30","value":-0.2740173969421846},{"time":"2020-12-30","value":0.02931108846373958},{"time":"2021-12-30","value":0.07453244132514199},{"time":"2022-12-30","value":0.07355038807233909},{"time":"2023-12-30","value":0.0032980300115775674}]}

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Sector

  • EHC Logo

    EHC

Growth

%

%

Discount

%

%

Multiple

g\r+10%+11%+12%+13%+14%
0%109887
+1%1110988
+2%13111098
+3%141311109
+4%1714121110
Years012345678910TV
FCF$92.44M$77.26M$64.58M$53.97M$45.11M$37.7M$31.51M$26.34M$22.01M$18.4M$15.38M$153.8M
DCF$67.18M$48.83M$35.49M$25.79M$18.74M$13.62M$9.901M$7.196M$5.23M$3.801M$38.01M
Value$273.8M

In the chart Earnings are multiplied by this value.

Earnings Growth -20%
Earnings Stability 29%


Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12-201512-201612-201712-201812-201912-202012-202112-202212-2023TTM
Net Margin12%10%9.3%7.4%-43%-46%6.9%3.4%-3%-3.5%
ROA12%11%8.2%7.5%-27%2.9%7.5%7.4%0.33%-0.31%
ROE14%12%10%8.7%-100%-110%15%7.4%-7.1%-8.2%

What is the average Net Margin?

The average Net Margin over the past 5 years is -12.33%.

What is the trend of Net Margin?

The trend of Net Margin over the past 5 years is +3.97%.

What is the average Return on Assets (ROA)?

The average ROA over the past 5 years is -0.3%.

What is the trend of Return on Assets (ROA)?

The trend of ROA over the past 5 years is +2.08%.

What is the average Return on Equity (ROE)?

The average ROE over the past 5 years is -30.47%.

What is the trend of Return on Equity (ROE)?

The trend of ROE over the past 5 years is +10.4%.


Safety & Stabiliy

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12-201512-201612-201712-201812-201912-202012-202112-202212-2023TTM
Debt FCF3.794.294.038.255.569.9512.304.325.700.18
Debt Equity0.530.630.610.641.172.341.120.740.760.02
MIN
Graham Stability--98%82%-490%-----490%

What is the Debt/FCF?

The Debt/FCF trailing twelve month is 0.18.

What is the trend of Debt/FCF?

The trend of Debt/FCF over the past 5 years is -0.40.

What is the Graham’s Stability?

Graham’s Stability measure stands at -4.92.


Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12-201612-201812-202012-2022Trend
Revenue-6.5%-11%4.8%1.1%-2.3%
Net Income-----8%
Stockholders Equity-16%-23%4.3%-4.8%-2.1%
FCF-17%-14%-14%-26%0.54%

What is the 5 year Revenue CAGR?

The Revenue CAGR over the past 5 years is -11.37%.

What is the trend of Revenue growth?

The trend of Revenue growth rate over the past 5 years is -2.3%.

What is the 5 year Earnings CAGR?

The Earnings CAGR over the past 5 years is -.

What is the trend of Earnings growth?

The trend of Earnings growth rate over the past 5 years is -7.97%.

What is the 5 year Equity CAGR?

The Equity CAGR over the past 5 years is -22.76%.

What is the trend of Equity growth?

The trend of Equity growth rate over the past 5 years is -2.07%.

What is the 5 year FCF CAGR?

The FCF CAGR over the past 5 years is -14.1%.

What is the trend of FCF growth?

The trend of FCF growth rate over the past 5 years is +0.54%.